MedTrace Logo

Programmed Intermittent Epidural Bolus Versus Continuous Infusion in Labour Analgesia

NCT03730753 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-11-30

No results posted yet for this study

Summary

This study aims to establish if programmed intermittent epidural bolus combined to patient controlled analgesia in labour analgesia will lower the hourly bupivacaine consumption when compared to continuous infusion combined with patient controlled analgesia. The investigators' hypothesis is that the use of programmed intermittent epidural bolus will lower the hourly bupivacaine consumption.

Conditions

  • Labor Pain

Interventions

DEVICE

Programmed intermittent epidural bolus

Programmed intermittent epidural bolus added to patient controlled epidural analgesia

DEVICE

Continuous infusion

Continuous infusion added to patient controlled epidural analgesia

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Geneviève Rivard, Dr. · Université de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2025-06-30
Completion
2025-06-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03730753 on ClinicalTrials.gov